Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
Abengoa, abolished, acetylsalicicylic, ADR, aesthetic, Afflelou, affordability, AFL, Agilent, AGIRC, AIDSVAX, Ajoutee, ALAE, Alain, Alfina, allied, Alnwick, Alopexx, altogether, Ambassador, amodiaquine, amortizable, Amplitude, Amundi, Andersen, andMinority, appendix, apro, Arab, areasare, ARRCO, ASAQ, asNet, asthenia, astronaut, atopic, Autocover, AVADO, awaken, background, bacterium, behavior, bellwether, Benzaclin, Berlin, bevacizumab, BFSA, bipar, BiTE, bloodstream, Brin, built, Bulgaria, buyer, BV, Caltech, CAT, categorized, Catherine, Cdiff, Centralised, certiorari, CET, CFE, CFO, Chachoengsao, Chattem, CHC, Chilcott, Chinoin, Cie, claimant, clarification, ClickStar, ClikSTAR, CoAprovel®and, coefficient, coli, compromising, Concordia, concrete, confederation, contraindicated, corneal, corruption, Corum, costsand, Cotisation, creditor, crime, Crohn, Crystallization, custodian, CVAE, cyclosporine, Debasish, debate, decentralised, degeneration, Delhi, deoxyribonucleic, dermatology, diphteria, discomfort, divestiture, Doliprane, donate, donation, Dorflex, DPU, Duluth, DuoPlavin, Dutch, Economique, edema, Eloxatin®in, EMA, Emerflu, ENSAE, Enterogermina, entrepreneurial, epidemic, equitystood, era, erectile, escitalopram, ESSEC, Essentiale, Estonia, etseq, extinguish, Extinguishing, facsimile, Farmaceutica, fault, FCPE, feature, fed, fermentation, Fiat, Fillon, Firstly, flourishing, FMD, Fnac, Fonciere, Foot, foster, founder, FOV, Fovea, Francisco, Fritsche, fromTeva, furthest, Galderma, GCP, GetGoal, GKV, Gold, Goodwillandintangible, graft, Guatemala, Gucci, hair, Hakko, Handok, HBV, heldin, Helvepharm, Hemisphere, HexaximTM, HMR, Holland, Hong, Hot, HP, HR, Humenza, HumenzaTM, Hyderabad, hydrogen, IBNR, ICH, ICSU, Icy, IDMC, Immunisation, Imperfecta, includesEquity, inconclusive, incubating, IND, inDiabetologia, indicationsper, Industria, infusional, ingestion, Innovationsince, instability, insulinApidra, Intensification, interferon, intravitreal, IPPC, IPV, itemsRestructuring, Kazakhstan, Kendrick, kill, Kirin, Kong, Kyowa, Lactacyd, landmarkATHENA, Laure, Lausanne, lean, Legion, Lelystad, lentivector, licence, licenced, LIFFE, likelihood, lineNet, lineRemeasurement, lixisenatide, lt, lymphoma, Maalox, macular, Magne, maker, Malta, mcg, Medley, melanin, mentoring, Merrimack, Merton, Metz, Micromet, Minsheng, miscalculate, mismatch, morning, Mouth, MRI, multichannel, multivitamin, nausea, needle, niche, nominee, NoSpa, NovoFine, NovoPen, occlusion, Oenobiol, ofAdacel, ofC, ofCopaxone, ofEcole, ofNet, ofPentacel, ofTaxotere®exceeded, omeprazole, oncologypipeline, ophthalmologic, ophthalmology, oriented, Ourdebt, outpatient, output, Panenza, PanenzaTM, parenchymal, parity, paroxysmal, PARP, PEG, PERCO, Peru, Petroleum, Pharmacenter, PhRMA, physicist, Piasa, plague, plaque, Plough, political, poly, polymerase, Porcheville, porcine, posology, prednisolone, prequalified, pressing, professionnelle, proliferation, prominent, Psychopharmacology, Pucci, Puerto, quantity, Quimica, rash, Rasuritek, ratified, rechargeable, redundancy, refresh, Regenerative, registrar, reign, Reiner, repeal, repealed, retinal, retinopathy, Roberto, Roneo, Rosenstock, Roychowdhury, Rubinstein, rural, Salk, Sanitaire, SAR, Sasa, sBLA, Schering, sciatica, Sculptra, Scuptra, se, seamlessly, seed, Selsun, semester, Semuloparin, sequence, ShanCholTM, ShanH, Shantha, shareholderspro, shrank, simpler, simplification, Singapore, slimming, SNC, Solaire, Solutionssince, sophisticated, SoRIE, sound, spin, Stargardt, StarLink®corn, Steering, Suisse, sulphate, sunset, suntan, surprise, suspicion, Swissmedic, Syntiron, taskforce, telex, Territoriale, TGA, theAgence, theIncome, theOrdre, theory, Thibaud, thinner, Thirdly, threat, threefold, TNBC, toNet, TotalFinaElf, tougher, Tourisme, toxin, traceability, TSU, tumorselective, Tunisia, Turin, Ukraine, unasserted, underpinned, underRestructuring, underSelling, underuse, Unisom, unitary, Universcience, upward, Usher, Uzbekistan, Valeo, Valeur, validly, vasodilatory, VELOUR, Venezuelan, VENICE, veritable, veterinary, vial, Vietnam, vii, virtue, VITAL, VL, VMS, vomiting, VRVg, warming, Warner, WCRX, weaker, Weinberg, Wellstat, WER, wet, whointer, withC, writ, wrote, younger, zoonotic
Removed:
absorption, additive, Agence, AHF, Air, Albemarle, ALFAUR, Allegra®, Allianz, amibegron, answering, antibiotic, anticancer, anticoagulation, anticompetitive, Antimicrobial, antiresorptive, antivascular, Arizona, arm, ASCO, attaching, AUR, avidin, awaited, awake, bacterial, Barbier, BASF, Becton, bind, binding, bioequipotency, biotin, bourse, bridge, bureau, canarypox, cannabinoid, cardiometabolic, CASSIOPEA, catheter, cellular, cerebrovascular, certify, chairmanship, Chamber, Chlamydia, cholesterol, chose, cilostazol, cirrhotic, citing, CLARINET, CLARITY, claudication, clinic, CMS, cognitive, Coley, commonly, complicate, Concession, congenital, consistently, consisting, Consortium, constriction, consultative, consulted, contractually, cooperative, Cordarone, corn, courtLandgericht, CpG, CRU, cure, CVC, Cytosine, dealt, delivering, Density, deployment, dermal, dianicline, Dickinson, differentiated, dilutional, dismissing, distinguishable, diversifying, divorced, Dormann, Dublin, DVT, DWS, dysglycemic, dyslipidemia, DyStar, economically, efficient, Elan, Eli, elicit, embolism, encouraging, England, enrich, enrolment, entailing, EQUINOX, escalating, Ethyl, evade, excellence, exchanged, EXCLAIM, explain, exploit, export, extract, Exubera, fastest, fasting, fewer, fiscaland, Fontaine, formally, formulary, forum, Franklin, FTC, Fur, GAD, gather, genital, Gent, glucocorticoid, GOGH, GRACE, grand, Griesheim, Guanine, haveexclusive, HCV, healthy, hemophilia, hook, Horizon, humanize, hyponatremia, identifying, idiopathic, IDM, idraparinux, IFPMA, IIIb, immunobiology, Immunodeficiency, immunogen, immunomodulator, immunotherapy, importation, INALCO, incentive, inflammatory, infusion, inhaled, initiating, innovator, inscription, inserm, Institut, inter, intermittent, invasive, investigating, investigational, irreversible, Israel, Israeli, Ivax, journal, kidney, knowledgeable, Labie, Lahey, Lastly, layer, LCM, leave, LLP, mainstay, married, MASCOT, matrix, maximize, MDD, Messer, methionine, MHLW, Michel, Mitsubishi, Montana, MRP, multivalent, myeloid, naked, NanoCrystal, neurodegenerative, neurology, neurotrophic, neutralizable, neutralization, Nevada, NICE, NOC, nocturnal, Northern, Nouveau, OAD, OptiClik, Ottawa, overhauled, overweight, paclitaxel, Path, pathogen, PCI, PE, penalty, penetration, pentasaccharide, peptide, petitioned, Pharmacopoeia, PICOLO, player, PMO, postmenopausal, Potasse, potent, PPC, prandial, predictable, prednisone, preference, Premier, preserved, prototype, PSTC, Psychiatric, pulmonary, recalculated, recruitment, refinancing, reject, Ren, render, researching, resection, resorption, resurfacing, reusing, risen, RMS, Roxane, Sabril, safely, sat, satavaptan, Scientifique, screening, seizure, Serre, serve, sexually, shipped, situated, sleeping, smoking, soluble, sparing, Spruchverfahren, StarLink, STEMI, stimulating, stopping, striking, subtotal, suffered, suppression, surgical, systemic, TaipeiEcole, Taiwan, Tarrytown, taxed, textile, Thai, Thann, theavoir, thechlamydia, thecontinucategory, titration, today, Transfert, transmitted, TRIST, twenty, ultra, Unallocated, undergone, unfractionated, unproductive, unresectable, unspecified, unutilized, urticaria, valuable, vasopressin, vehicle, visual, vitamin, Warburg, week, Wellesley, whistleblower, withdraw
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 1.1 Articles of Association (Statuts) of Sanofi-aventis (English Translation)
- 12.1 Certification of Christopher Viehbacher, CEO, Required by Section 302.
- 12.2 Certification of Jerome Contamine, Pfo, Required by Section 302.
- 13.1 Certification of Christopher Viehbacher, CEO, Required by Section 906.
- 13.2 Certification of Jerome Contamine, Pfo, Required by Section 906.
- 23.1 Consent of Ernst & Young Audit
- 23.2 Consent of Pricewaterhousecoopers Audit
- 99.1 Report of the Chairman of the Board of Directors for 2009.
SNY similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-157685, 333-149203, 333-145074, 333-139555, 333-125490, 333-121584, 333-121583, and 333-107238) of sanofi-aventis, of our reports dated March 9, 2010, with respect to the consolidated financial statements of sanofi-aventis and its subsidiaries and the effectiveness of internal control over financial reporting of sanofi-aventis, included in this Annual Report (Form 20-F) for the year ended December 31, 2009.
ERNST & YOUNG Audit
Represented by Christian Chiarasini and Jacques Pierres
Paris-La Défense, France
March 12, 2010